XML 30 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity (Deficit) (Tables)
3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation, Allocation of Recognized Period Costs
Total stock-based compensation expense for employees and non-employees recognized in the statements of operations was as follows (in thousands):
 
 
 
 
 
Three Months Ended March 31,
 
2018
 
2017
 
(unaudited)
Research and development
$
426

 
$
177

General and administrative
396

 
139

Total stock-based compensation expense
$
822

 
$
316

 
 
 
 
Schedule of Stock Option Activity
The table below summarizes stock option and restricted award activity under the 2011 and 2018 Plan:
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of Shares Outstanding
 
Weighted-Average Exercise Price
 
Weighted- Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value (in thousands)
Balances at December 31, 2017
 
 
2,506,926

 
$
3.50

 
8.79
 
$
24,033

Forfeited
 
 
(6,772
)
 
7.01

 
 
 
 
Granted
 
 
5,600

 
31.58

 
 
 
 
Balances at March 31, 2018
 
 
2,505,754

 
$
3.57

 
8.58
 
$
85,225